000963 Huadong Medicine
- 32.87
- +0.47+1.45%
Huadong Medicine News
Huadong Pharmaceutical: 2023 Profit Distribution Plan Announcement
Huadong Pharmaceutical: Announcement on the completion of the cancellation of some restricted stock repurchases
Huadong Pharmaceutical: Announcement on the pledge and cancellation of the pledge of some of the shares of the controlling shareholder
Huadong Pharmaceutical: Announcement on the pledge and cancellation of the pledge of some of the shares of the controlling shareholder
Huadong Pharmaceutical: Announcement on the controlling shareholder\'s partial share pledge
Huadong Pharmaceutical: Reminder Notice on the 2022 Restricted Stock Incentive Plan for the First Grant of Restricted Stocks to Restricted Stocks, First Release Period, and Release of Restricted Shares from Listing and Circulation
Huadong Pharmaceutical: Announcement on the 2022 Restricted Stock Incentive Plan for the First Time Granting Restricted Stocks to Restricted Stocks, First Release Period, and Achievements in Lifting Sales Restriction Conditions
Huadong Pharmaceutical: Guosheng Securities Co., Ltd.\'s independent financial adviser report on Huadong Pharmaceutical Co., Ltd.\'s 2022 restricted stock incentive plan for the first time granting restricted shares, the first lifting period, and the achie
Huadong Pharmaceutical: The Supervisory Committee\'s verification opinions on the company\'s 2022 restricted stock incentive plan for the first time granting restricted stocks, the first lifting period, lifting the conditions for lifting the restrictions,
Huadong Pharmaceutical: Announcement on Adjusting the Repurchase Price of the 2022 Restricted Stock Incentive Plan
Huadong Pharmaceutical: Zhejiang Tianze Law Firm\'s Legal Opinion on Huadong Pharmaceutical Co., Ltd.\'s 2022 Restricted Stock Incentive Plan Grants Restricted Stocks for the First Time Restricted Stocks, First Release Period, and Achievements in Lifting C
Huadong Pharmaceutical: Announcement on the repurchase and cancellation of some restricted stocks
Huadong Pharmaceutical: Notice on the completion of registration of reservation grants for the 2022 Restricted Stock Incentive Plan
East China Pharmaceutical: Explanation of the inspection opinions and publicity of the board of supervisors on the list of incentive recipients granted to reserve restricted stocks under the company\'s 2022 restricted stock incentive plan
Huadong Pharmaceutical: Notice on Adjusting the Reserve Price of the Company\'s 2022 Restricted Stock Incentive Plan
Huadong Pharmaceutical: Legal Opinions of Zhejiang Tianze Law Firm on the Price Adjustment and Grant of Reserved Restricted Shares under Huadong Pharmaceutical Co., Ltd.\'s 2022 Restricted Stock Incentive Plan
East China Pharmaceutical: Audit Opinions of the Board of Supervisors on the Company\'s 2022 Restricted Stock Incentive Plan Reserve List of Incentive Targets (Date of Grant)
Huadong Pharmaceutical: Notice on Granting Reserved Restricted Shares to Incentive Recipients of the 2022 Restricted Stock Incentive Plan
Huadong Pharmaceutical: Announcement on the pledge and cancellation of the pledge of some of the shares of the controlling shareholder
Huadong Pharmaceutical: 2022 Annual Equity Distribution Implementation Notice
Analysis
Price Target
No Data
